Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Sooil Development Co., Ltd. — Predicate Candidate Screening

4 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K071418DANA 3CC SYRINGE INSULIN RESERVOIRSooil Development Co., Ltd.2007-09-041050
K063126DANA DIABECARE IISSooil Development Co., Ltd.2007-02-021120
K022317DANA DIABECARE II INSULIN PUMP & SUPERLINE-EASYRELEASE, SOFTSooil Development Co., Ltd.2002-08-02160
K001604DANA DIABECARESooil Development Co., Ltd.2000-08-14820

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda